Gexval

Fujisawa, Japan

Gexval is a healthcare company that helps patients and families fighting against orphan and intractable diseases.

$1.9M raised

Jan 2025

Series C

Top Investors

Mitsubishi UFJ CapitalSMBC Venture CapitalTakedaOita Venture CapitalYokohama Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gexval raised?

Gexval has raised $1.9M in total funding. The most recent round was Series C. The last funding was announced in January 2025.

Who are Gexval's investors?

Gexval's investors include Mitsubishi UFJ Capital, SMBC Venture Capital, Takeda, Oita Venture Capital, Yokohama Capital.

Where is Gexval headquartered?

Gexval is headquartered in Fujisawa, Japan.

What does Gexval do?

Gexval is a healthcare company that helps patients and families fighting against orphan and intractable diseases.

What stage is Gexval at?

Gexval is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 16, 2025.

MLA

"Gexval — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/gexval. Accessed June 4, 2026.

APA

VCBacked. (2025). Gexval — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gexval

Wikipedia (cite web)

{{cite web |title=Gexval — Funding & Investors |url=https://www.vcbacked.co/company/gexval |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 16, 2025.